M

MRNA

MRNA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio6% buys
BearishBullish
MRNA Live QuoteReal-time
$195.00
$7.63(-3.77%)1M
Day Range$191.46 – $210.00
Open$200.07
Previous Close$199.33
Volume9.64M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$80.65B
P/E Ratio (TTM)24.5
Forward P/E23.0
EPS (TTM)$-7.04
Price to Book11.7
Dividend Yield0.65%
Beta (Volatility)1.17
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $195.00 (67%)
Low: $23.55High: $280.80
Wall Street Consensus
Buy
Analyst Rating
4.1/ 5.0
Target Price
$164.53+9.7% upside

Insider Buys

2

$6.01M

Insider Sales

24

$98.75M

Total Volume

$104.75M

47 transactions

Net Activity

$92.74M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
60CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Heavy distribution: sales represent 94% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •High accumulation: total purchase value exceeds $1M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale+OE Insiders

0 buys21 sells

$3409.79B total

H
2

Hoge Stephen

Pres

0 buys10 sells

$62.39M total

B
3

Bancel Stephane

CEO

1 buys1 sells

$33.72M total

M
4

Mock James M

CFO

0 buys2 sells

$4.75M total

K
5

Klinger Shannon Thyme

GC

0 buys6 sells

$1.47M total

Trading History
MRNA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 16, 2026

5 days ago

Hoge Stephen

Pres

President
Sell78.4K$215.63$16.90M

Oct 14, 2026

1 months ago

Hoge Stephen

Pres

President
Sell78.4K$217.10$17.01M

Oct 14, 2026

1 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.79M$-78369.00$0

Sep 14, 2026

2 months ago

Hoge Stephen

Pres

President
Sell80.6K$145.10$11.69M

Sep 14, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.72M$-80575.00$0

Sep 10, 2026

2 months ago

Mock James M

CFO

CFO
Sell34.8K$134.49$4.69M

Sep 10, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell59.4K$-34836.00$0

Sep 1, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell75.2K$-3471.00$0

Sep 1, 2026

2 months ago

Klinger Shannon Thyme

GC

General Counsel
Sell3.5K$139.95$486K

Aug 5, 2026

3 months ago

Bancel Stephane

CEO

CEO
Sell499.2K$57.52$28.72M

Aug 5, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell22.22M$-499246.00$0

Jul 15, 2026

4 months ago

Hoge Stephen

Pres

President
Sell53.3K$67.60$3.61M

Jul 15, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.64M$-53336.00$0

Jun 15, 2026

5 months ago

Hoge Stephen

Pres

President
Sell53.3K$51.37$2.74M

Jun 15, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.64M$-53336.00$0

Jun 4, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell73.6K$-3471.00$0

Jun 4, 2026

5 months ago

Klinger Shannon Thyme

GC

General Counsel
Sell3.5K$50.00$174K

May 21, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell6.86M$-9263.00$0

May 21, 2026

6 months ago

Afeyan Noubar

Dir

Director
Sell9.3K$46.84$434K

May 15, 2026

6 months ago

Hoge Stephen

Pres

President
Sell53.3K$48.40$2.58M

May 15, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.63M$-53336.00$0

May 1, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell12.1K$-5682.00$0

May 1, 2026

6 months ago

Hussain Abbas

Dir

Director
Sell5.7K$46.63$265K

Mar 2, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell59.7K$-13885.00$0

Mar 2, 2026

8 months ago

Klinger Shannon Thyme

GC

General Counsel
Sell13.9K$52.29$726K

Feb 23, 2026

9 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.61M$-160009.00$0

Feb 23, 2026

9 months ago

Hoge Stephen

Pres

President
Sell160.0K$48.84$7.81M

Dec 11, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell6.86M$-23853.00$0

Dec 11, 2025

11 months ago

Afeyan Noubar

Dir

Director
Sell23.9K$29.49$703K

Dec 9, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.5K$-504.00$0

Dec 9, 2025

11 months ago

Hussain Abbas

Dir

Director
Sell504$27.60$14K

Jun 11, 2025

17 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell580$-312.00$0

Jun 11, 2025

17 months ago

Hussain Abbas

Dir

Director
Sell312$28.00$9K

Mar 3, 2025

20 months ago

Bancel Stephane

CEO

CEO
Buy160.3K$31.22$5.00M

Mar 3, 2025

20 months ago

Sagan Paul

Dir

Director
Buy31.6K$31.76$1.00M

Mar 3, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell21.27M$160314.00$3409.79B

Dec 9, 2024

23 months ago

Klinger Shannon Thyme

GC

General Counsel
Sell529$44.68$24K

Dec 9, 2024

23 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell20.4K$-529.00$0

Dec 3, 2024

23 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell19.8K$-112.00$0

Dec 3, 2024

23 months ago

Klinger Shannon Thyme

GC

General Counsel
Sell112$43.30$5K

Dec 3, 2024

23 months ago

Hoge Stephen

Pres

President
Sell314$43.30$14K

Nov 29, 2024

24 months ago

Hoge Stephen

Pres

President
Sell291$42.79$12K

Nov 29, 2024

24 months ago

Klinger Shannon Thyme

GC

General Counsel
Sell1.4K$42.79$61K

Nov 29, 2024

24 months ago

Mock James M

CFO

CFO
Sell1.4K$42.79$61K

Nov 29, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell11.1K$-1420.00$0

Nov 11, 2024

24 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.60M$-277.00$0

Nov 11, 2024

24 months ago

Hoge Stephen

Pres

President
Sell277$46.10$13K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
MRNA Buy Conviction6%
Industry Rank#106 of 569
Volume Contribution0.6%
Total Industry Activity$16.52B

MRNA has an insider buy conviction of 6%, compared to the Unknown sector buy average of 6%. MRNA ranks #106 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for MRNA

Over the last 90 days, corporate insiders at MRNA (MRNA) engaged in a total of 47 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 24 were sales. The total volume of insider trading reached $104.75M.

The net insider activity for MRNA shows a net selling bias of $92.74M. This activity represents a 6% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 21.27M shares valued at $3409.79B on Mar 3, 2025.

Live Market News & Developments
Aggregated real-time headlines for MRNA (MRNA)
6 updates

mRNA-1283 Associated With Lower Risk of Medically Attended COVID-19 Than BNT162b2 in Older Veterans

Pharmacy Times5h ago

What A Cancer Vaccine Stumble Means For Moderna Stock

Trefis14h ago

MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?

Yahoo Finance38d ago

Moderna drops marking longest losing streak since 2024

Seeking Alpha2d ago

Moderna Shares Are Up 350% in 2026. Is the Stock a Buy Now?

Morningstar87d ago

Moderna (NASDAQ:MRNA) Stock Price Up 4.9% - Here's Why

MarketBeat7h ago

FAQs About MRNA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for MRNA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for MRNA is currently 60/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 2 purchases and 24 sales by company executives over the last 90 days.

The CEO Conviction Index for MRNA is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.